雷珠单抗治疗视网膜中央静脉阻塞并发黄斑水肿的报告
目的：探讨玻璃体腔内注射雷珠单抗治疗视网膜中央静脉阻塞并发黄斑水肿的临床疗效。方法：选取2015—03／09我院收治的视网膜中央静脉阻塞并发黄斑水肿患者30例30眼行雷珠单抗玻璃体腔内注射，1次／mo，治疗1～3mo，治疗结束后随诊3mo，比较患者注射后最佳矫正视力、眼压、黄斑中心凹视网膜厚度、黄斑水肿消退率及眼底荧光血管造影检查结果。结果：随着雷珠单抗注射次数的增加，患者的最佳矫正视力逐渐提高（P〈0．05），黄斑中心凹视网膜厚度明显下降（P〈0．05），眼压与治疗前比较并无明显变化（P〉0．05）。第1、2、3次注射后患者黄斑水肿消退率分别为47％、68％、94％。结论：玻璃体腔内注射雷珠...
Saved in:
| Published in | 国际眼科杂志 Vol. 16; no. 4; pp. 767 - 769 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
523059,中国广东省东莞市人民医院眼科
2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | 目的：探讨玻璃体腔内注射雷珠单抗治疗视网膜中央静脉阻塞并发黄斑水肿的临床疗效。方法：选取2015—03／09我院收治的视网膜中央静脉阻塞并发黄斑水肿患者30例30眼行雷珠单抗玻璃体腔内注射，1次／mo，治疗1～3mo，治疗结束后随诊3mo，比较患者注射后最佳矫正视力、眼压、黄斑中心凹视网膜厚度、黄斑水肿消退率及眼底荧光血管造影检查结果。结果：随着雷珠单抗注射次数的增加，患者的最佳矫正视力逐渐提高（P〈0．05），黄斑中心凹视网膜厚度明显下降（P〈0．05），眼压与治疗前比较并无明显变化（P〉0．05）。第1、2、3次注射后患者黄斑水肿消退率分别为47％、68％、94％。结论：玻璃体腔内注射雷珠单抗能够有效缓解视网膜中央静脉阻塞继发的黄斑水肿，明显改善患者的视力。 |
|---|---|
| AbstractList | 目的：：探讨玻璃体腔内注射雷珠单抗治疗视网膜中央静脉阻塞并发黄斑水肿的临床疗效。方法：选取2015-03/09我院收治的视网膜中央静脉阻塞并发黄斑水肿患者30例30眼行雷珠单抗玻璃体腔内注射,1次/mo,治疗1~3mo,治疗结束后随诊3mo,比较患者注射后最佳矫正视力、眼压、黄斑中心凹视网膜厚度、黄斑水肿消退率及眼底荧光血管造影检查结果。结果：随着雷珠单抗注射次数的增加,患者的最佳矫正视力逐渐提高(P<0.05),黄斑中心凹视网膜厚度明显下降(P<0.05),眼压与治疗前比较并无明显变化(P>0.05)。第1、2、3次注射后患者黄斑水肿消退率分别为47%、68%、94%。结论：玻璃体腔内注射雷珠单抗能够有效缓解视网膜中央静脉阻塞继发的黄斑水肿,明显改善患者的视力。 目的：探讨玻璃体腔内注射雷珠单抗治疗视网膜中央静脉阻塞并发黄斑水肿的临床疗效。方法：选取2015—03／09我院收治的视网膜中央静脉阻塞并发黄斑水肿患者30例30眼行雷珠单抗玻璃体腔内注射，1次／mo，治疗1～3mo，治疗结束后随诊3mo，比较患者注射后最佳矫正视力、眼压、黄斑中心凹视网膜厚度、黄斑水肿消退率及眼底荧光血管造影检查结果。结果：随着雷珠单抗注射次数的增加，患者的最佳矫正视力逐渐提高（P〈0．05），黄斑中心凹视网膜厚度明显下降（P〈0．05），眼压与治疗前比较并无明显变化（P〉0．05）。第1、2、3次注射后患者黄斑水肿消退率分别为47％、68％、94％。结论：玻璃体腔内注射雷珠单抗能够有效缓解视网膜中央静脉阻塞继发的黄斑水肿，明显改善患者的视力。 |
| Abstract_FL | AlM:To investigate the clinical effect of intravitreal injection of Ranibizumab for macular edema caused by central retinal vein occlusion( CRVO) .METHODS:Selected 30 patients (30 eyes) from March~September 2015 in our hospital with CRVO complicated by macular edema were treated with intravitreal injection of ranibizumab, 1 time per month, 1 ~3mo as one course. After treatments, all patients were followed up for 3mo. The best corrected visual acuity ( BCVA ) , intraocular pressure ( lOP ) , central macular thickness and macular edema regressive rate and fundus fluorescein angiography were compared and analyzed. RESULTS: With the increase of injection times of ranibizumab, BCVA in patients had a gradual increase (P<0. 05). Central macular thickness significantly decreased (P<0. 05), and lOP had no significant change (P>0. 05). After the 1st, 2nd and 3th injection, the macular edema regressive rates were 47%, 68%, 94%.CONCLUSlON:lntravitreal injection of ranibizumab can significantly relieve the macular edema caused by CRVO and improve BCVA of the patients. |
| Author | 赖静怡 杜驰 马萍萍 刘清洋 陈敏瑜 |
| AuthorAffiliation | 中国广东省东莞市人民医院眼科,523059 |
| AuthorAffiliation_xml | – name: 523059,中国广东省东莞市人民医院眼科 |
| Author_FL | Jing-Yi Lai Chi Du Qing-Yang Liu Min-Yu Chen Ping-Ping Ma |
| Author_FL_xml | – sequence: 1 fullname: Jing-Yi Lai – sequence: 2 fullname: Chi Du – sequence: 3 fullname: Ping-Ping Ma – sequence: 4 fullname: Qing-Yang Liu – sequence: 5 fullname: Min-Yu Chen |
| Author_xml | – sequence: 1 fullname: 赖静怡 杜驰 马萍萍 刘清洋 陈敏瑜 |
| BookMark | eNo9j0tLAlEAhe_CICv_hLsWM9079znLkMpAaONeZu44NpbXcojQZYiQEDKLtDcFRasiInog0Z9pXv8iw2h14PDxHc4cyKimqgKQR1DHpoBLdd3zfaUjxg2NIgPrBkRMJzoRGZD9b2dBzvc9G0JBsMG4yIJiev4WD67Do-OoP4qex_FwlNz34s8g6V18vz-Et4_p5WnSPUxPxuHNVfjxGg6CdNyNhkH09JIcfMVn3ah_Fwb9BTDjWtt-NfeX86C8ulIuFLXSxtp6YbmkSYaEZjBqC2E6DoIcE-zY0OaQEoc4tnBNCyIspAOpDSlEXEpGJTFdg2EuMZayKvE8WJxq9y3lWqpWqTf3WmoyWGl0avX2VqfzexwSSMSEzU9ZudlUtV1vQu-0vIbValcYE5hQgwv8A_2Nd1k |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3980/j.issn.1672-5123.2016.4.48 |
| DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Report of intravitreal injection of Ranibizumab for macular edema caused by central retinal vein occlusion |
| DocumentTitle_FL | Report of intravitreal injection of Ranibizumab for macular edema caused by central retinal vein occlusion |
| EndPage | 769 |
| ExternalDocumentID | mzgjykzz201604048 668345278 |
| GrantInformation_xml | – fundername: 2012年度广东省东莞市科技计划医疗卫生类科研项目(No.201210515000531)@@@@2012 Science and Technology Plan Project for Health Care of Dongguan Guangdong funderid: (201210515000531) |
| GroupedDBID | --- -05 2RA 5VS 92L ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 GROUPED_DOAJ IPNFZ OK1 RIG RNS U1G U5O W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| ID | FETCH-LOGICAL-c618-265b889dd107343db0b7054d4db8f9a0138cd05b05017cc65c49f2637c33ccec3 |
| ISSN | 1672-5123 |
| IngestDate | Wed Nov 06 04:20:26 EST 2024 Wed Feb 14 10:21:05 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | 玻璃体腔内注射 视网膜中央静脉阻塞 central retinal vein occlusion 雷珠单抗 macular edema intravitreal injection 黄斑水肿 ranibizumab |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c618-265b889dd107343db0b7054d4db8f9a0138cd05b05017cc65c49f2637c33ccec3 |
| Notes | ranibizumab; central retinal vein occlusion; macular edema; intravitreal injection 61-1419/R AIM：To investigate the clinical effect of intravitreal injection of Ranibizumab for macular edema caused by central retinal vein occlusion（CRVO）.METHODS：Selected 30 patients（30 eyes） from MarchSeptember 2015 in our hospital with CRVO complicated by macular edema were treated with intravitreal injection of ranibizumab,1 time per month,1 ~3mo as one course.After treatments,all patients were followed up for 3mo.The best corrected visual acuity（BCVA）,intraocular pressure（IOP）,central macular thickness and macular edema regressive rate and fundus fluorescein angiography were compared and analyzed.RESULTS：With the increase of injection times of ranibizumab,BCVA in patients had a gradual increase（P〈 0.05）.Central macular thickness significantly decreased（P〈 0.05）,and IOP had no significant change（P〉 0.05）.After the 1st,2nd and 3th injection,the macular edema regressive rates were 47%,68%,94%.CONCLUSION：Intravitreal injection o |
| PageCount | 3 |
| ParticipantIDs | wanfang_journals_mzgjykzz201604048 chongqing_primary_668345278 |
| PublicationCentury | 2000 |
| PublicationDate | 2016 |
| PublicationDateYYYYMMDD | 2016-01-01 |
| PublicationDate_xml | – year: 2016 text: 2016 |
| PublicationDecade | 2010 |
| PublicationTitle | 国际眼科杂志 |
| PublicationTitleAlternate | International Journal of Ophthalmology |
| PublicationYear | 2016 |
| Publisher | 523059,中国广东省东莞市人民医院眼科 |
| Publisher_xml | – name: 523059,中国广东省东莞市人民医院眼科 |
| SSID | ssib008432678 ssj0000870305 ssib022561425 ssib017477466 ssib051371031 ssib001104025 ssib038075119 |
| Score | 2.075528 |
| Snippet | ... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 767 |
| SubjectTerms | 玻璃体腔内注射 视网膜中央静脉阻塞 雷珠单抗 黄斑水肿 |
| Title | 雷珠单抗治疗视网膜中央静脉阻塞并发黄斑水肿的报告 |
| URI | http://lib.cqvip.com/qk/83813A/201604/668345278.html https://d.wanfangdata.com.cn/periodical/mzgjykzz201604048 |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1La9RAOLT14kUUFWtVijjHXfOYzOM4k2Ypgp4q9LZskk1LxW3V9uAepRQsSNmDrW8UFC8qIuKDIv4Z9_Uv_L5JdjdtFaqwLJNvvnzPZL5vJvOwrEupHbk8oXhMKo9LEG9ZSUIgKIk6r4mabdc901G8eo3NXqdX5v35sfF3hVlLa6tROW7-cV3J_3gVYOBXXCX7D54dEgUAlMG_8A8ehv9D-ZiEkkhNNCchJ6JClE1Cn4gZIn0SMiIUkRwL2iVaI45kBiKIAnyGEA3IDkLgUgYkpERD7QzSUZSo0LAAHGlwIPGUBiIMQcBxiAyxoCXRzHCvGIISEQAfuCNTx4hhE00NHZCnYuRROQ6Iqny8HTCFKmbMBqhRTuQrifDNjQHRARZAkYw4CAlkURIQYBhckZv2UYSRHgxndyhnhGJuRuUlUSC3PaoxABUgFWmjYQeFEQpoLNAeqJ8w0jHUUujieEq20NM8-zg-7kt4svfYOtcws2Mlr5JBrqpwChBgEg6MbkyJVQp_mYnRHCBUYDxkTKbcgyYrBCPG3RIkZN6eaMUKbyUthB6eHWuSZzE8OwBnf4D0pJlRumQYlIcMcIojK9Nytunpvg3IbzYXlu7eaDYRB5p8KsatIy40635hAMMk39CzL36zFhS6BqPN4iBwQCo4qseTDvAj9uDadzyOZ44MR0htYaIRjpgM5Mx2DUYlLv9dBdwlZXG5sXALcj-zFK-R1hoLhaxx7rh1LO_uTavs3T1hjTUXT1qz_adfu1sv2w8edjZ3Op92u9s7vbcb3R-t3sazX9_et19_6D9_3Fu_33-02371ov39S3ur1d9d72y3Oh8_9-797D5Z72y-abc2T1lzlXAumC3lJ5qUYuZA28X8SAiZJA4EVuolkR1x6DIlNIlEKms4aSBObB9sAXEyjpkfU5m6zOOx58VxPfZOWxON5Ub9jDUdeTKR0k0SWaNU8KjGnBRy8TjlUWoLGU1aU0MjVFeyjWuqjAmP-i4Xk9bF3CzVvDm7Uz3g5rOHQZqyjmI5G5Q8Z02s3l6rn4c0fTW6YJ6O348rsxE |
| link.rule.ids | 315,783,787,867,4031,27935,27936,27937 |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%9B%B7%E7%8F%A0%E5%8D%95%E6%8A%97%E6%B2%BB%E7%96%97%E8%A7%86%E7%BD%91%E8%86%9C%E4%B8%AD%E5%A4%AE%E9%9D%99%E8%84%89%E9%98%BB%E5%A1%9E%E5%B9%B6%E5%8F%91%E9%BB%84%E6%96%91%E6%B0%B4%E8%82%BF%E7%9A%84%E6%8A%A5%E5%91%8A&rft.jtitle=%E5%9B%BD%E9%99%85%E7%9C%BC%E7%A7%91%E6%9D%82%E5%BF%97&rft.au=%E8%B5%96%E9%9D%99%E6%80%A1&rft.au=%E6%9D%9C%E9%A9%B0&rft.au=%E9%A9%AC%E8%90%8D%E8%90%8D&rft.au=%E5%88%98%E6%B8%85%E6%B4%8B&rft.date=2016&rft.pub=523059%2C%E4%B8%AD%E5%9B%BD%E5%B9%BF%E4%B8%9C%E7%9C%81%E4%B8%9C%E8%8E%9E%E5%B8%82%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E7%9C%BC%E7%A7%91&rft.issn=1672-5123&rft.volume=16&rft.issue=4&rft.spage=767&rft.epage=769&rft_id=info:doi/10.3980%2Fj.issn.1672-5123.2016.4.48&rft.externalDocID=mzgjykzz201604048 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F83813A%2F83813A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fmzgjykzz%2Fmzgjykzz.jpg |